PB1768: IS NATIVE E-COLI OR PEG-ASPERAGINASE FORMULATION A HIGHER RISK FOR VTE DEVELOPMENT IN PATIENTS WITH POST TREATMENT ACUTE LYMPHOBLASTIC LEUKEMIA? A META-ANALYSIS

por Seki, J. T., Atenafu, E., Sibai, H.
Publicado 2022

P1020: SCREENING FOR PORTAL HYPERTENSION IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

por Davidson, M., Wong, F., Atri, M., Sibai, H., Maze, D., Cheung, V., Nye, T., Callum, J., Atenafu, E., Gupta, V.
Publicado 2022

PREDICTORS OF TUMOR DYNAMICS DURING A COURSE OF 30-FRACTION RADIOTHERAPY FOR GLIOBLASTOMA

por Ong, W L, Stewart, J, Sahgal, A, Soliman, H, Tseng, C L, Detsky, J, Ho, L, Das, S, Maralani, P, Lipsman, N, Stanisz, G, Perry, J, Chen, H, Atenafu, E, Lau, A, Ruschin, M, Myrehaug, S
Publicado 2023